First Analysis Upgrades Praxair To Overweight

By: via Benzinga
First Analysis upgraded Praxair (NYSE: PX) from Equal-weight to Overweight. The target price for Praxair is set to $155. Praxair ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.